Peter C. O’Brien
Peter C. O’Brien publishes mostly in Neurology, Radiology, Nuclear Medicine and Imaging and Physiology, on topics such as Dementia and Cognitive Impairment Research, Pain Mechanisms and Treatments and Botulinum Toxin and Related Neurological Disorders.
- World rank
- #38,020 of 7,710,434 ranked researchers
- Rank in United States
- #14,547 of 1,627,098
- Works
- 569
- Citations
- 56k
- Citations per work
- 98.7
What does Peter C. O’Brien research?
Peter C. O’Brien's work is mostly in Medicine (31%), Mathematics (5%).
Their six largest subfields, inside their fields and domains; the grey slice is everything else they publish. The interactive view splits every one of their works down to single topics.
The fields and subfields, with their numbers
- Everything else36463.9%
- Health Sciences17631.0%
- Medicine17631.0%
- Physical Sciences295.1%
- Mathematics295.1%
- 1Neurology8% of their works
- 2Radiology, Nuclear Medicine and Imaging6% of their works
- 3Physiology6% of their works
- 4Surgery5% of their works
- 5Pulmonary and Respiratory Medicine5% of their works
- 6Statistics and Probability5% of their works
Research topics
- Dementia and Cognitive Impairment Research
- Pain Mechanisms and Treatments
- Botulinum Toxin and Related Neurological Disorders
- Statistical Methods in Clinical Trials
- Lymphoma Diagnosis and Treatment
- Alzheimer's disease research and treatments
- Peripheral Neuropathies and Disorders
- Parkinson's Disease Mechanisms and Treatments
Which keywords describe Peter C. O’Brien's research?
The keywords of their largest research topics: Biomarkers, Neuroinflammation, Neurological Disorders, Treatment, Alzheimer's Disease, Mild Cognitive Impairment, Neurodegeneration and Oxidative Stress.
- a-Synuclein
- Guillain-Barré Syndrome
- Tau Pathology
- Lymphoma
- False Discovery Rate
- Neurotoxins
- Neuropathic Pain
- Oxidative Stress
- Mild Cognitive Impairment
- Treatment
- Neuroinflammation
- Biomarkers
- Neurological Disorders
- Alzheimer's Disease
- Neurodegeneration
- Central Sensitization
- Botulinum Toxin
- Adaptive Designs
- Classification
- Amyloid Hypothesis
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy
- Parkinson's Disease
Size is their works in the topics tagged with each word, from their 8 largest topics. Each links to the topic it comes from most. The words come from the keyword list OpenAlex gives each topic, not from the text of the papers, so a word can appear that none of the papers uses.
All 22 words, with their numbers
- Biomarkers752 topics
- Neuroinflammation602 topics
- Neurological Disorders572 topics
- Treatment572 topics
- Alzheimer's Disease441 topic
- Mild Cognitive Impairment441 topic
- Neurodegeneration442 topics
- Oxidative Stress442 topics
- Central Sensitization351 topic
- Neuropathic Pain351 topic
- Botulinum Toxin341 topic
- Neurotoxins341 topic
- Adaptive Designs311 topic
- False Discovery Rate311 topic
- Classification301 topic
- Lymphoma301 topic
- Amyloid Hypothesis251 topic
- Tau Pathology251 topic
- Chronic Inflammatory Demyelinating Polyradiculoneuropathy231 topic
- Guillain-Barré Syndrome231 topic
- Parkinson's Disease191 topic
- a-Synuclein191 topic
Where does Peter C. O’Brien work?
Peter C. O’Brien's main affiliation in the publication record is Mayo Clinic, United States.
How many publications and citations does Peter C. O’Brien have?
OpenAlex counts 569 works and 56,151 citations for Peter C. O’Brien, an h-index of 118, ranking #38,020 of 7,710,434 researchers worldwide on the quality score.
Ranked on field-normalised citation excellence (50%), output (30%) and citations (20%). Counts come from OpenAlex author records, which occasionally merge different people who share a name or split one person into several.
Other researchers named Peter C. O’Brien
Papers, co-authors, who cited this work and researchers on the nearest topics have tabs of their own, above. Is this your page? Claim it with your ORCID iD, or request a correction or removal.
Discussion
Ask a question or share a note about Peter C. O’Brien. Keep it to the research: no personal attacks, advertising or links. Any reader can report a post, which collapses it for everyone until it is opened.